Updates and controversies for desmoids in familial adenomatous polyposis
Open Access
- 20 June 2025
- journal article
- review article
- Published by Springer Nature in Familial Cancer
- Vol. 24 (3) , 1-10
Abstract
Desmoids are rare non-cancerous fibrous growths with variable behavior ranging from slow indolent growth or even regression, to locally aggressive and progressive tumors that can cause significant morbidity or mortality. Approximately 10–15% of patients with familial adenomatous polyposis (FAP) develop desmoid disease, most commonly located in the abdomen, on the abdominal wall, or in limbs. The majority of desmoids in FAP occur after abdominal surgery. Management is quite challenging and employing a multidisciplinary team at a specialized center is important for success. New treatment modalities have emerged, including tyrosine kinase inhibitors, γ-secretase inhibitors, and ablation techniques, complementing the existing repertoire of therapies such as NSAIDs, anti-hormonal therapy, chemotherapy, radiotherapy, and surgical interventions. Surgery remains the treatment of choice for easily resectable abdominal wall desmoids and intra-abdominal desmoids that cause intractable symptoms, or progressive disease despite alternate therapies, or complications from the invasion of nearby organs. When considering prophylactic colectomies in FAP patients, it’s essential to account for the desmoidogenic potential of surgical interventions, especially in high-risk individuals with a positive family history of desmoids, presence of extracolonic manifestations and carriers of certain genotypes. Given the rarity of the disease and the variability in both anatomical presentation and clinical course, desmoids should be managed by a multidisciplinary team capable of coordinating patient specific care and optimizing treatment options.Keywords
This publication has 66 references indexed in Scilit:
- Intestinal transplantation for the treatment of desmoid tumors associated with familial adenomatous polyposisSurgery, 2001
- Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposisInternational Journal of Cancer, 2001
- Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)Oncogene, 1999
- Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene.1996
- Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444Human Molecular Genetics, 1995
- Desmoid tumours in familial adenomatous polyposis.Gut, 1994
- Familial adenomatous polyposis (FAP): Frequency, penetrance, and mutation rateHuman Mutation, 1994
- Desmoid tumors of the chest wall. A locally recurrent problem.1992
- Hereditary cancer, oncogenes, and antioncogenes.1985
- Thoracic Wall Desmoid Tumor in a ChildThe Annals of Thoracic Surgery, 1973